Reported 1 day ago
In his first week back in office, President Trump revoked a proposed $2 drug list for common generics designed to lower prescription costs for Medicare patients, a plan that was intended to save seniors $2 billion annually but was never implemented. This decision highlights contrasting approaches to Medicare management and raises questions regarding future drug price negotiations under his administration.
Source: YAHOO